MAPT and Alzheimer disease: Moreover, the PRS is associated with AD-related phenotypes, such as brain volumes [10–12], brain amyloid-beta (Aβ) burden [11, 12], and plasma phosphorylated tau [13], and has been reported to be useful in predicting conversion from mild cognitive impairment (MCI) to AD [14, 15].